Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New study highlights misunderstanding surrounding risks and benefits of tamoxifen

22.03.2004


Use of tamoxifen by high risk women is low due to both failure of doctors to offer it and patients’ refusal to accept it, according to the results of a new study led by researchers at Northwestern Memorial Hospital. While tamoxifen chemoprevention has been shown to reduce the occurrence of breast cancer by nearly 50 percent in women with elevated risk, this study shows that the drug’s risks and benefits aren’t always appropriately evaluated when determining who should take it.



The study, which will be published March 22, 2004 in the online edition of CANCER, is the largest to date to review use of the drug in risk-eligible women.

"The study shows that doctors tend to offer tamoxifen to women who will reap the greatest benefit from the drug due to risk caused by certain types of benign breast disease and to those at lower risk of severe side effects. That makes sense," explains Monica Morrow, M.D., the study’s lead author and director of breast surgery at Northwestern Memorial Hospital. "What doesn’t make sense is that women significantly less likely to have side effects, such as premenopausal women and those without a uterus, did not accept tamoxifen more frequently than other groups." Dr. Morrow is also a professor of surgery at Northwestern University’s Feinberg School of Medicine.


"There clearly is a lot of confusion among women about the risks and benefits of tamoxifen chemoprevention," continues Dr. Morrow. "Our findings indicate a great deal of misunderstanding about tamoxifen’s risks and benefits among women, probably due to all the negative press it has gotten over the years. They also indicate that we need better educational strategies to help women make this decision."

Study researchers analyzed data from 219 women with increased breast cancer risk to identify clinical factors that would predict its use. Overall, only 63 percent of the women were offered tamoxifen and only 26 percent accepted. The authors conclude, "Our findings indicate that both physician practice and the attitudes of at risk women are responsible for low rates of tamoxifen usage."

The United States Food and Drug Administration approved tamoxifen in 1998 for breast cancer risk reduction in women with elevated breast cancer risk. The worldwide data showed an average 38 percent risk reduction in breast cancer for all risk-eligible women, although the largest U.S. trial showed a 49 percent reduction. Women with atypical hyperplasia (AH) or lobular carcinoma in situ (LCIS) derived the greatest benefit – e.g., an absolute risk reduction of 86 percent for women with AH in one study. Approximately 2.4 million women are estimated to be eligible to benefit from tamoxifen.


Article: "Acceptance of Tamoxifen Chemoprevention by Physicians and Women at Risk," Julia Tchou, Nanjiang, Hou, Alfred Rademaker, V. Craig Jordan, and Monica Morrow, CANCER; Published Online March 22, 2004; Print Issue Date: May 1, 2004.


About Northwestern Memorial Hospital

Northwestern Memorial Hospital (NMH) is one of the country’s premier academic medical centers and is the primary teaching hospital of Northwestern University’s Feinberg School of Medicine. Northwestern Memorial and its Prentice Women’s Hospital and Stone Institute of Psychiatry have 744 beds and more than 1,200 affiliated physicians and 5,000 employees. Providing state-of-the-art care, NMH is recognized for its outstanding clinical and surgical advancements in such areas as cardiothoracic and vascular care, gastroenterology, neurology and neurosurgery, oncology, organ and bone marrow transplantation, and women’s health.

Northwestern Memorial was ranked as the nation’s 5th best hospital by the 2002 Consumer Checkbook survey of the nation’s physicians and is listed in the majority of specialties in this year’s US News & World Report’s issue of "America’s Best Hospitals." NMH is also cited as one of the "100 Best Companies for Working Mothers" by Working Mother magazine and has been chosen by Chicagoans year after year as their "most preferred hospital" in National Research Corporation’s annual survey.

Patty Keiler | EurekAlert!
Further information:
http://www.nmh.org/

More articles from Health and Medicine:

nachricht Correct antibiotic dosing could preserve lung microbial diversity in cystic fibrosis
22.02.2019 | Children's National Health System

nachricht Researchers find trigger that turns strep infections into flesh-eating disease
19.02.2019 | Houston Methodist

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: (Re)solving the jet/cocoon riddle of a gravitational wave event

An international research team including astronomers from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has combined radio telescopes from five continents to prove the existence of a narrow stream of material, a so-called jet, emerging from the only gravitational wave event involving two neutron stars observed so far. With its high sensitivity and excellent performance, the 100-m radio telescope in Effelsberg played an important role in the observations.

In August 2017, two neutron stars were observed colliding, producing gravitational waves that were detected by the American LIGO and European Virgo detectors....

Im Focus: Light from a roll – hybrid OLED creates innovative and functional luminous surfaces

Up to now, OLEDs have been used exclusively as a novel lighting technology for use in luminaires and lamps. However, flexible organic technology can offer much more: as an active lighting surface, it can be combined with a wide variety of materials, not just to modify but to revolutionize the functionality and design of countless existing products. To exemplify this, the Fraunhofer FEP together with the company EMDE development of light GmbH will be presenting hybrid flexible OLEDs integrated into textile designs within the EU-funded project PI-SCALE for the first time at LOPEC (March 19-21, 2019 in Munich, Germany) as examples of some of the many possible applications.

The Fraunhofer FEP, a provider of research and development services in the field of organic electronics, has long been involved in the development of...

Im Focus: Regensburg physicists watch electron transfer in a single molecule

For the first time, an international team of scientists based in Regensburg, Germany, has recorded the orbitals of single molecules in different charge states in a novel type of microscopy. The research findings are published under the title “Mapping orbital changes upon electron transfer with tunneling microscopy on insulators” in the prestigious journal “Nature”.

The building blocks of matter surrounding us are atoms and molecules. The properties of that matter, however, are often not set by these building blocks...

Im Focus: University of Konstanz gains new insights into the recent development of the human immune system

Scientists at the University of Konstanz identify fierce competition between the human immune system and bacterial pathogens

Cell biologists from the University of Konstanz shed light on a recent evolutionary process in the human immune system and publish their findings in the...

Im Focus: Transformation through Light

Laser physicists have taken snapshots of carbon molecules C₆₀ showing how they transform in intense infrared light

When carbon molecules C₆₀ are exposed to an intense infrared light, they change their ball-like structure to a more elongated version. This has now been...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Global Legal Hackathon at HAW Hamburg

11.02.2019 | Event News

The world of quantum chemistry meets in Heidelberg

30.01.2019 | Event News

Our digital society in 2040

16.01.2019 | Event News

 
Latest News

JILA researchers make coldest quantum gas of molecules

22.02.2019 | Physics and Astronomy

Understanding high efficiency of deep ultraviolet LEDs

22.02.2019 | Materials Sciences

Russian scientists show changes in the erythrocyte nanostructure under stress

22.02.2019 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>